• 1. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
• 2. Exchangeability of amino acid residues with similar physicochemical properties in coiled-coil interactions?
  Guiying Zhang,Maosheng Cheng,Yanni Li,Keliang Liu,Lifeng Cai Chem. Commun., 2013,49, 11086-11088
• 3. Enabling chloride salts for thermal energy storage: implications of salt purity?
  J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608
• 4. Evolution study of photo-synthesized gold nanoparticles by spectral deconvolution model: a quantitative approach
  Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735
• 5. Evolution of hierarchical porous structures in supramolecular guest–host hydrogels?
  Christopher B. Rodell,Christopher B. Highley,Minna H. Chen,Neville N. Dusaj,Chao Wang,Lin Han,Jason A. Burdick Soft Matter, 2016,12, 7839-7847

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazines Phenylpyrimidines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazines Pyrimidines and pyrimidine derivatives Phenylpyrimidines

Introduction to 6-(2-Methoxyphenyl)pyrimidine-2,4(1H,3H)-dione (CAS No. 116137-74-7)

6-(2-Methoxyphenyl)pyrimidine-2,4(1H,3H)-dione, identified by the Chemical Abstracts Service Number (CAS No.) 116137-74-7, is a heterocyclic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal biology. This compound belongs to the pyrimidine derivatives, a class of molecules widely recognized for their biological activity and therapeutic potential. The structural framework of 6-(2-Methoxyphenyl)pyrimidine-2,4(1H,3H)-dione consists of a pyrimidine core substituted with a 2-methoxyphenyl group at the 6-position and a dione moiety at the 2 and 4 positions. This unique structural configuration imparts distinct chemical and biological properties, making it a valuable scaffold for drug discovery and development.

The pyrimidine scaffold is a fundamental motif in biochemistry, playing a crucial role in nucleic acid structures and various enzymatic processes. Pyrimidine derivatives have been extensively explored for their pharmacological properties, with numerous compounds entering clinical trials for diverse therapeutic applications. The introduction of substituents such as the 2-methoxyphenyl group can modulate the electronic and steric properties of the molecule, influencing its interactions with biological targets. In particular, the 2-methoxyphenyl group enhances lipophilicity and can improve membrane permeability, which is often critical for drug bioavailability.

The dione functionality in 6-(2-Methoxyphenyl)pyrimidine-2,4(1H,3H)-dione contributes to its reactivity and potential for further chemical modification. Diones are known to participate in various chemical reactions, including condensation reactions with nucleophiles, which can be exploited to synthesize more complex derivatives. This reactivity makes it a versatile intermediate in synthetic chemistry, allowing for the exploration of novel analogs with tailored biological activities.

Recent advancements in computational chemistry and molecular modeling have facilitated the rational design of heterocyclic compounds like 6-(2-Methoxyphenyl)pyrimidine-2,4(1H,3H)-dione. These computational tools enable researchers to predict binding affinities, optimize molecular structures, and identify potential lead compounds with high precision. The integration of machine learning algorithms has further accelerated this process by analyzing large datasets of known bioactive molecules. Such innovations have significantly enhanced the efficiency of drug discovery pipelines.

In the realm of medicinal biology, 6-(2-Methoxyphenyl)pyrimidine-2,4(1H,3H)-dione has been investigated for its potential pharmacological effects. Preliminary studies suggest that this compound may exhibit inhibitory activity against certain enzymes and receptors implicated in various diseases. For instance, pyrimidine derivatives have shown promise in targeting kinases and other enzymes involved in cancer pathways. The presence of the 2-methoxyphenyl group may enhance binding interactions with specific amino acid residues in these targets, leading to potent inhibitory effects.

One notable area of research has been the exploration of 6-(2-Methoxyphenyl)pyrimidine-2,4(1H,3H)-dione as a candidate for treating inflammatory disorders. Pyrimidine-based compounds have demonstrated anti-inflammatory properties by modulating signaling pathways such as NF-κB and MAPK. The structural features of this compound may allow it to interfere with pro-inflammatory mediators, thereby reducing inflammation without significant side effects. Further investigation into its mechanism of action could uncover new therapeutic strategies for chronic inflammatory conditions.

Another promising application lies in neurodegenerative diseases. Pyrimidine derivatives have been reported to cross the blood-brain barrier efficiently due to their favorable physicochemical properties. This characteristic makes them suitable candidates for treating neurological disorders such as Alzheimer's disease and Parkinson's disease. Studies indicate that compounds like 6-(2-Methoxyphenyl)pyrimidine-2,4(1H,3H)-dione may exert neuroprotective effects by inhibiting oxidative stress and promoting neuronal survival.

The synthesis of 6-(2-Methoxyphenyl)pyrimidine-2,4(1H,3H)-dione involves multi-step organic reactions that require precise control over reaction conditions. Advanced synthetic methodologies have been employed to achieve high yields and purity levels. Techniques such as palladium-catalyzed cross-coupling reactions have been particularly useful in constructing complex heterocyclic frameworks efficiently. These synthetic advances have enabled the rapid production of analogs for biological testing.

In conclusion,6-(2-Methoxyphenyl)pyrimidine-2,4(1H,3H)-dione (CAS No. 116137-74-7) represents a structurally intriguing compound with significant potential in pharmaceutical research. Its unique combination of functional groups makes it an attractive scaffold for developing novel therapeutic agents targeting various diseases. Ongoing research efforts are focused on elucidating its biological mechanisms and optimizing its pharmacological properties through structure-activity relationship studies.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)